|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Net accretion of discount on investment securities and net realized investment gains | |||||
| Noncash lease expense on operating leases | |||||
| Depreciation and amortization | |||||
| Impairment loss on right-of-use assets | |||||
| Impairment loss on long-lived assets | |||||
| Stock-based compensation | |||||
| Amortization of deferred contract costs | |||||
| Impairment of capitalized internal-use software | |||||
| (Gain) loss on disposal of assets | |||||
| Gain on disposal of property and equipment | |||||
| Other, net | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Deferred revenue and other liabilities, non-current | |||||
| Operating lease liabilities | |||||
| Other long-term liabilities | |||||
| Net cash provided by (used in) operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Purchases of marketable securities | |||||
| Maturities of marketable securities | |||||
| Proceeds from disposal of property and equipment | |||||
| Purchases of property and equipment | |||||
| Capitalized internal-use software costs | |||||
| Net cash (used in) provided by investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Principal payments on finance lease and lease financing obligations | |||||
| Proceeds from issuance of common stock upon public offering, net of underwriting discounts and commission and other offering costs | |||||
| Payments of offering costs | |||||
| Proceeds from debt facility | |||||
| Repayment of debt facility | |||||
| Payment of debt issuance costs | |||||
| Proceeds from insurance premium financing | |||||
| Principal payments on insurance premium financing | |||||
| Proceeds from lease financing obligations | |||||
| Purchase of treasury stock | |||||
| Proceeds from exercises of stock options | |||||
| Taxes paid for net share settlement of equity awards | |||||
| Proceeds from ESPP | |||||
| Net cash (used in) provided by financing activities | |||||
| Net (decrease) increase in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash, beginning of period | |||||
| Cash and cash equivalents and restricted cash, end of period | |||||
| SUPPLEMENTAL INFORMATION: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes | |||||
| Cash paid for operating lease liabilities | |||||
| NON-CASH INVESTING AND FINANCING ACTIVITIES: | |||||
| Stock-based compensation included in property and equipment and capitalized internal-use software | |||||
| Accrued bonus classified as stock-based compensation | |||||
| Financed insurance premiums included in accrued expenses and other current liabilities | |||||
| Bonus plan expense classified as stock-based compensation | |||||
| Equipment acquired through finance lease and lease financing obligations | |||||
| Accruals related to purchases of property and equipment | |||||
| Lease liabilities arising from right-of-use assets upon adoption of ASC 842 | |||||
| Assets obtained in exchange for operating lease obligations | |||||
| Receivable recorded due to stock option exercises pending settlement | |||||
| Accrued bonus settled in restricted stock units | |||||
| RECONCILIATION OF CASH, CASH EQUIVALENTS AND RESTRICTED CASH | |||||
| Cash and cash equivalents | |||||
| Restricted cash – included in prepaid expenses and other current assets | |||||
| Restricted cash, non-current | |||||
Loading...